rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Lifeward Ltd. -

LFWD · Nasdaq

Health CareMedical DevicesNot moving yet

LFWD stood above a rising 150-day average in 4 of the last 52 weekly readings, and has been out of that trend for the last 13 weeks. It is 15.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 13
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
8 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.6M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders8+0 on the quarter
New · exited1 · 1
Reported value$250K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CITADEL ADVISORS LLCnew · filed 14 Aug 202618,064$142K+18,064
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 202611,327$87K-100−0.9%
UBS Group AGadded · filed 13 Aug 20262,152$16K+27+1.3%
MORGAN STANLEYadded · filed 13 Aug 2026274$2,099+66+31.7%
SBI Securities Co., Ltd.unchanged · filed 23 Jul 2026196$1,50100.0%
OSAIC HOLDINGS, INC.unchanged · filed 14 Aug 2026107$83600.0%
NATIONAL BANK OF CANADAunchanged · filed 10 Aug 202611$8500.0%
Caitong International Asset Management Co., Ltdunchanged · filed 5 Aug 20264$3100.0%
31 Mar 2024 – 30 Jun 2026
81521Mar 24Sep 24Jun 25Dec 25Jun 26

Everyone who traded it

Avraham Gabay Company insiderDirector · last 20 Aug 20260 · 0
Haggai Zamir Company insiderDirector · last 14 Aug 20260 · 0
Yonason Greenwald Company insiderDirector · last 14 Aug 20260 · 0
Keith Dale Rose Company insiderChief Medical Officer · last 1 May 20260 · 0
Almog Adar Company insiderChief Financial Officer · last 25 Mar 20260 · 0
Miriam Kidron Company insiderDirector · last 25 Mar 20260 · 0
Moshe H. Rozenbaum Company insiderDirector · last 25 Mar 20260 · 0
Nadav Kidron Company insiderDirector · last 25 Mar 20260 · 0
William Mark Grant Company insiderPresident & CEO · last 25 Mar 20260 · 0
William Mark Sigsbee Company insiderDirector · last 25 Mar 20260 · 0
Yehuda Reznick Company insiderDirector · last 25 Mar 20260 · 0
Jeannine Lynch Company insiderVP of Market Access & Strategy · last 11 Dec 20250 · 7

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%
PLSE Pulse BiosciencesLeading+33%
INFU InfuSystems HoldingsLeading+27%
SMTI Sanara MedTechLeading+26%
ITGR Integer HoldingsLeading+23%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202538.2%
Operating profit marginFY 2025 · to 31 Dec 2025-89.3%
Free cash flow marginFY 2025 · to 31 Dec 2025-76.4%
Return on capital employedFY 2025 · to 31 Dec 2025-181%
Interest coverFY 2025 · to 31 Dec 202563.06×
Research spendFY 2025 · to 31 Dec 202514.7%
Share count trendFY 2025 · to 17 Mar 20260.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$2.2M
Free cash flowFY 2025 · to 31 Dec 2025−$16.8M

Analyst forecasts

No analyst forecasts yet.